Open Access

High Impact List of Articles

• Sublingual Immunotherapy in Real-Life: When and Why
  Maurizio Marogna*

  Review Article:

Conference Proceedings

• Phase-I/IIa trial of chimeric antigen receptor modified T-cells against CD133 in patients with sorafenib refractory hepatocellular carcinoma (HCC) and other solid tumors
  Weidong Han

  Scientific Tracks Abstracts: Immunotherapy: Open Access

• Sequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome
  Orly Avni

  Scientific Tracks Abstracts: Immunome Research

Relevant Topics in